Harry started experiencing seizures at 5 months of age. After analysis, it was discovered that he had a mutation in the Gabra 1 gene, which is associated with severe epilepsy. At first, his medication didn't work very well, and after trying 7 different anti-epileptic drugs, he was offered VNS Therapy.
This is Harry's story living with VNS Therapy epilepsy treatment.
THIS VIDEO IS INTENDED FOR AUDIENCES IN THE OUS (NON-USA) REGION. The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients whose epileptic disorder is dominated by partial seizures (with or without secondary generalization) or generalized seizures that are refractory to seizure medications. The most common side effects with VNS Therapy are hoarseness, shortness of breath, sore throat and coughing. These side effects generally only occur during stimulation and usually decrease over time. The most common side effect of the surgical procedure is infection. For important safety information, visit www.vnstherapy.co.uk/safety-information